Form 15

August 15, 2011

/s/ Robert W. Weber

Robert W. Weber

Chief Financial Officer and Secretary

0001193125-11-222260.txt : 20110815 0001193125-11-222260.hdr.sgml : 20110815 20110815090046 ACCESSION NUMBER: 0001193125-11-222260 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110815 DATE AS OF CHANGE: 20110815 EFFECTIVENESS DATE: 20110815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Harbor BioSciences, Inc. CENTRAL INDEX KEY: 0000899394 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133697002 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-24672 FILM NUMBER: 111033306 BUSINESS ADDRESS: STREET 1: 9171 TOWNE CENTRE DRIVE STREET 2: SUITE 180 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 858-587-9333 MAIL ADDRESS: STREET 1: 9171 TOWNE CENTRE DRIVE STREET 2: SUITE 180 CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: HOLLIS EDEN PHARMACEUTICALS INC /DE/ DATE OF NAME CHANGE: 19970410 FORMER COMPANY: FORMER CONFORMED NAME: INITIAL ACQUISITION CORP DATE OF NAME CHANGE: 19930329 15-12G 1 d1512g.htm FORM 15 Form 15

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.


Commission File Number		001-34584

HARBOR BIOSCIENCES, INC.

(Exact name of registrant as specified in its charter)

9191 Towne Centre Drive, Suite 409

San Diego, California 92122

(858) 587-9333

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, par value $0.01 per share

(Title of each class of securities covered by this Form)

None

(Title of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:


Rule 12g-4(a)(1)		x
Rule 12g-4(a)(2)		¨
Rule 12h-3(b)(1)(i)		¨
Rule 12h-3(b)(1)(ii)		¨
Rule 15d-6		¨

Approximate number of holders of record as of the certification or notice date: 299

Pursuant to the requirements of the Securities Exchange Act of 1934, Harbor BioSciences, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.